FindTrial
Sign In

Renal protection of dexmedetomidine in patients undergoing major abdominal surgery

Renal protection of dexmedetomidine in patients undergoing major abdominal surgery

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2300073505
Enrollment
Unknown
Registered
2023-07-12
Start date
2023-07-20
Completion date
Unknown
Last updated
2023-07-16

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

acute kidney injury

Interventions

Experimental group:none
Control group:none

Sponsors

West China Hospital, Sichuan University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 100 Years

Inclusion criteria

Inclusion criteria: From January 2019 to July 2021, all adult patients undergoing major abdominal surgery

Exclusion criteria

Exclusion criteria: Age<18 years; Emergency operation; Operation duration<2 hours; Preoperative end-stage renal dysfunction patients (eGFR<15); Preoperative dialysis patients; Patients without main index (preoperative and postoperative creatinine value);

Design outcomes

Primary

MeasureTime frame
incidence of acute kidney injury;—

Secondary

MeasureTime frame
renal injury markers;total hospitalization days;mortality during hospitalization;incidence of dialysis;incidence of hypotention;incidence of bradycardia;—

Countries

China

Contacts

Public ContactWensheng Zhang

West China Hospital, Sichuan University

zhang_ws@scu.edu.cn+86 189 8060 1564

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026